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Abstract
Background: Molecular sensing in the gastro-intestinal (GI) tract is responsible for the detection of ingested harmful 
drugs and toxins, thereby genetic polymorphisms affecting the capability of initiating these responses may be critical 
for the subsequent efficiency of the gut in eliminating possible threats to the organism. Although these fundamental 
control systems have been known for long time, the initial molecular recognition events that sense the chemical 
composition of the luminal contents of the GI tract have remained elusive. TAS2R14 is one of the better characterized 
members of the taste receptor family and has several polymorphic variants. Several substances that have been shown 
to activate TAS2R14 are powerful toxic and carcinogenic agents.
Methods: Using a tagging approach we investigated all the common genetic variation of the gene region in relation 
to colon cancer risk with a case-control study design. This is, at the best of our knowledge also the first report on the 
allele frequencies of the gene in the Caucasian population.
Results: We found no evidence of statistically significant associations between polymorphisms in the TAS2R14 gene 
and colon cancer risk.
Conclusion: In conclusion we can confidently exclude a major role for common polymorphisms of the TAS2R14 gene 
in colorectal cancer risk in this population, although in this report we had insufficient statistical power to completely 
exclude the possibility that rare variants of the TAS2R14 might be involved in colorectal cancer risk.
Background
The gustatory system has been selected during evolution
to detect non-volatile nutritive and beneficial compounds
as well as potentially harmful substances. In particular,
bitter taste has evolved as a central warning signal against
the ingestion of potentially toxic substances, including
plant alkaloids and other environmental toxins. Recently,
the most studied family of bitter taste receptors (referred
as TAS2Rs) [1] has been characterized not just in the
tongue but also in the gut[2]. The gastrointestinal (GI)
mucosa comes in direct contact with a vast array of
potentially harmful substances in the lumen and acts as a
sensory organ by detecting luminal content and sending
messages to the nervous system to initiate the appropri-
ate response of neutralization and expulsion of drugs,
toxins, and microorganisms. While it is true that certain
ligands that activate TAS2Rs are biotransformed to elimi-
nate their toxicity, the biotransformation of other ligands
can increase toxicity. The first, and perhaps strongest,
line of defense against toxins may be at the level of taste
by avoiding ingestion.
As a second line of defence molecular sensing in the GI
tract could be responsible for the detection of ingested
harmful drugs and toxins, thereby initiating responses
critical for survival. Furthermore, molecular sensing of
luminal contents also initiates hormonal and/or neural
pathways leading to the regulation of caloric intake, pan-
creatic insulin secretion, and metabolism [3].
Although these fundamental control systems have been
known for a considerable amount of time, the initial
molecular recognition events that sense the chemical
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Page 2 of 6composition of the luminal contents of the GI tract have
remained elusive. Indeed, the receptors and signaling
pathways that transduce the effects of many luminal mol-
ecules have not been identified, and the cellular and neu-
ral pathways that mediate biological responses to luminal
stimuli in general, and bitter stimuli in particular, remain
poorly characterized.
In humans, bitter taste is mediated by approximately 30
G protein-coupled receptors belonging to the TAS2R
gene family [4-6]. Some of TAS2Rs receptors are nar-
rowly tuned for their corresponding ligands. However
recent reports have shown that several, including
TAS2R14, have extremely broad spectra for activation
towards a large variety of putative bitter tastants that are
structurally very divergent[7,8]. This feature of TAS2R14
might explain how the limited number of bitter taste
receptors enables mammals to recognise thousands of
different bitter tasting molecules.
Several bitter substances that have been shown to acti-
vate TAS2R14 are powerful toxic agents like picrotoxin,
which is an antagonist of GABAA-receptors leading to
neurotoxic effects including convulsant action in human
and rodents [7] and aristolochic acid, which is a strong
carcinogen that nonetheless is used as an herbal remedy
for weight loss. These findings suggest that this receptor
indeed is a functional warning sensor of the concentra-
tions of potentially harmful compounds within food con-
taining those substances.
Genetic variants affecting the capability of initiating
these responses may be critical for the subsequent effi-
ciency of the gut in eliminating possible threats to the
organism[3]. TAS2R14 is one of the better characterized
members of the T2R family and has several polymorphic
variants. Although functional studies did not elucidate
the biological relevance of the single nucleotide polymor-
phisms (SNPs) in this gene, several studies have been
conducted in the other members of the T2R family with
promising results [9-11].
We conducted a study to investigate the hypothesis that
genetic variants of TAS2R14 could influence its ability to
bind bitter toxic compound, initiate the elimination of
xenobiotic and thus increase the risk of colorectal cancer.
Using a tagging approach we covered all the genetic vari-
ation of the gene, and tested tagging SNPs in 680 cases of
colon cancer and 590 controls.
Methods
Study population
For the present case-control study, six oncological and
five large gastroenterological departments in various
regions of the Czech Republic contributed by providing
blood samples and anamnestic data. The study is based
on incident cases, whose recruitment started in Septem-
ber 2004 and finished in February 2006.
Cases consist of patients with positive colonoscopic
results for malignancy, histologically confirmed as colon
or rectal carcinomas. In the group of cases, genetic test-
ing for hereditary HNPCC was recommended to four
patients, who belonged to families complying with the
Amsterdam criteria II. These patients were excluded
from our study.
Controls were sampled at the same time as cases, and
chosen among subjects undergoing colonoscopy due to
macroscopic bleeding, positive fecal occult blood test, or
abdominal pain of unknown origin. The most common
findings for these subjects were hemorrhoids or idiopatic
bowel diseases (IBD). Only subjects whose colonoscopic
results were negative for malignancy, colorectal ade-
nomas or IBD were chosen as controls.
Study subjects provided information on their lifestyle
habits (smoking, drinking, diet etc.), tentative occupa-
tional exposure to xenobiotics, and family/personal his-
tory of cancer, with the use of structured questionnaires
[12,13].
We included in this study 680 cases and 590 controls.
The relevant characteristic of the studied population are
shown in table 1. The genetic analyses did not interfere
with diagnostic or therapeutic procedures for the sub-
jects. All participants signed an informed written consent
and the design of the study was approved by the Ethical
Committee of the Institute of Experimental Medicine,
Prague, Czech Republic.
Selection of tagging SNPs
We aimed at surveying the entire set of common genetic
variants in TAS2R14. To this end, we followed a tagging
approach. We used the algorithm described by Carlson
and coworkers [14] that was developed to select the max-
imally informative set of tagSNPs in a candidate-gene
association study. All polymorphisms in the region of
TAS2R14 (including 5 kb upstream of the first exon and 5
kb downstream of the last exon) with minor allele fre-
quency (MAF) ≥ 5% in Caucasians from the International
HapMap Project (version 21a; http://www.hapmap.org)
were included. Tagging SNPs were selected with the use
of the Tagger program within Haploview http://
www.broad.mit.edu/mpg/haploview/; http://
www.broad.mit.edu/mpg/tagger/[15,16], using pairwise
tagging with a minimum r2 of 0.8. This resulted in a selec-
tion of 3 tagging SNPs, with a mean r2 of the selected
SNPs with the SNPs they tag of 1, meaning that our selec-
tion captures completely the known common variability
in this gene. Considering that the genomic region of
TAS2R14 is characterized by high levels of linkage disqui-
librium (LD), we postulate that such SNPs are also likely
to tag any hitherto unidentified common SNPs in the
gene. Figure 1 shows TAS2R14 and its selected tagging
SNPs.
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Cases Controls
(n = 680) (n = 590)
Males/Females (%)* 57.2/48.2 53.6/46.4
Age Average 61.1 yrs 56.0 yrs
Lower Quartile 55 yrs 47 yrs
Upper quartile 69 yrs 66 yrs
Rectal cancer (%) 38.4
Colon cancer (%) 61.7
Smoking* Non smokers (%) 53.6 52.8
Ex-smokers (%) 32.3 26.4
Smokers (%) 14.1 20.9
Alcohol consumption* no (%) 47.3 40.2
yes (%) 52.7 59.8
Mean g of alcohol/day* 23.1 22.9
Living Place* City (%) 57.2 56.2
Suburbs (%) 15.5 21.2
Country (%) 27.3 22.7
Education* Basic (%) 33.5 25.4
High School (%) 51.6 54.8
University (%) 14.9 19.8
Mean BMI (Kg/m2) ± SD* 26.7 ± 4.3 26.7 ± 4.5
Distribution of the populations according to BMI:* < 18.5 Kg/m2 (%) 1.56 0.73
18.5-24.9 Kg/m2 (%) 37.0 37.9
25-29.9 Kg/m2 (%) 42.5 41.5
30-34.9 Kg/m2 (%) 15.1 15.3
≥ 35 Kg/m2 (%) 3.80 4.61
* No statistically significant differences were found for these covariates, between cases and controls
DNA extraction and genotyping
DNA was extracted from blood samples with standard
proteinase K digestion followed by phenol/chloroform
extraction and ethanol precipitation. The order of DNAs
of cases and controls was randomized on PCR plates in
order to ensure that an equal number of cases and con-
trols could be analyzed simultaneously. All genotyping
was carried out using the Taqman assay. The MGB Taq-
man probes and primers were purchased from Applied
Biosystems (Foster City, CA) as pre-designed assays. The
reaction mix included 10 ng genomic DNA, 10 pmol each
primer, 2 pmol each probe and 2.5 ml of 2× master mix
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mocycling included 40 cycles with 30 s at 95°C followed
by 60 s at 60°C. PCR plates were read on an ABI PRISM
7900HT instrument (Applied Biosystems).
All samples that did not give a reliable result in the first
round of genotyping were resubmitted to up to two addi-
tional rounds of genotyping. Data points that were still
not filled after this procedure were left blank. Repeated
quality control genotypes (8% of the total) showed an
average concordance of 99.9%.
Statistical Analysis
The frequency distribution of genotypes was examined
for the cases and the controls. Hardy-Weinberg equilib-
rium was tested in the cases and in the controls separately
by chi square test. We used logistic regression for multi-
variate analyses to assess the main effects of the genetic
polymorphism on CRC risk using a codominant inheri-
tance model. The most common allele in the controls was
assigned as the reference category. All analyses were
adjusted for age and sex.
Additionally, we performed a logistic regression strati-
fying for the cancer site (colon versus rectum), smoking
habits (smokers versus non smokers and heavy smokers
versus light smokers (were considered heavy smokers
those individuals that smoked more than 20 cigarettes a
day), alcohol consumption and BMI (both considered as a
continuous variable).
All analyses were performed with STATA software
(StataCorp, College Station, TX).
Results
Cases and controls were similar in terms of gender distri-
bution. We analyzed the frequencies and distributions of
the genotypes in cases and in controls. The genotype dis-
tributions at all loci were in Hardy-Weinberg equilibrium
in controls, with non-significant chi square values (p <
0.05, data not shown).
We used the Tagger software to check the extent of LD
between the SNPs we selected. As expected, we found
very low LD between the selected tagging SNPs (Figure
1). The frequencies and distribution of the genotypes and
the odds ratios for the association of each polymorphism
with colorectal cancer risk are described in Table 2.
We found no statistically significant association
between TAS2R14 SNPs and colorectal cancer risk.
Since several polymorphism in T2R genes have been
found to be associated to behavioural traits like smoking
habit and alcohol consumption or anthropometric mea-
sures like body mass index (BMI), and these variables are
considered to be risk factors for colorectal cancer, we also
performed analysis on possible association between the
tagging SNPs and BMI, alcohol consumption, smoking
behaviour We also stratified the analysis by cancer loca-
tion (colon vs rectum) and measured the above men-
tioned variables both separately for cases and controls
and pooling them together.
We found that carriers of the G allele of the SNP
rs11610105 were more likely to be light smokers rather
than being heavy smokers (number of cigarettes/day> =
20), with an odds ratio of 0.31 (95% confidence interval
0.16-0.64, P = 0.001). This association was observed only
in the heterozygous individuals and just in controls.
We did not find any other association between the
TAS2R14 gene polymorphisms and the measured end-
points.
Discussion
Bitter taste has evolved as a central warning signal against
the ingestion of potentially toxic substances, including
plant alkaloids and other environmental toxins. Recently,
TAS2R family members have been characterized in the
gut [2]. The GI mucosa comes in direct contact with a
vast array of potentially harmful substances in the lumen
and acts as a sensory organ and is, therefore, responsible
for the detection of ingested harmful drugs and toxins.
Thereby SNPs affecting the capability of initiating these
responses may be critical for the subsequent efficiency of
the gut in eliminating possible threats to the organism[3].
Furthermore, molecular sensing of luminal contents also
initiates hormonal and/or neural pathways leading to the
regulation of caloric intake, pancreatic insulin secretion,
and metabolism [3].
Several TAS2Rs receptors are narrowly tuned for their
corresponding ligands. However recent reports have
Figure 1 TAS2R14 locus and its tagging SNPs. From top to bottom: 
SNPs genotyped in HapMap, graphical representation of LD and block 
structure (darker color represents higher LD, numbers in the colored 
squares are percentage of LD, expressed as r2; absence of number 
means r2 = 100%). Asterisks denote tagging SNPs selected for genotyp-
ing.
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broad spectra for activation. towards a large variety of
putative bitter tastants that are structurally very diver-
gent.
TAS2R14 has been shown to be activated by various
substances, several of which are powerful toxic agents
like picrotoxin and aristolochic acid which is a strong car-
cinogen, that nonetheless is used as an herbal remedy for
weight loss.
In this case-control study, we explored the role of three
tagging polymorphisms in the TAS2R14 gene. Since bitter
taste sensitivity has been reported to be associated with
smoking and alcohol consumption [17-19], we explored
at the same time the association of TAS2R14 common
variants with anthropometric measures, behavioural
traits like smoking and alcohol consumption and colorec-
tal cancer susceptibility.
A gene-wide tagging approach is currently accepted as
the model for genetic association studies [20]. We
selected tagging SNPs in order to cover all the genetic
variance of TAS2R14 with a minimum threshold of r2>0.8
and MAF >0.05. However, the real r2 with which our tag-
ging SNPs tagged the other polymorphic variants in the
gene was 1. Therefore we covered all the common
(MAF>0.05) known genetic variability of this gene
achieving thus a complete survey of the possible associa-
tion between the polymorhisms and the endpoints taken
into account.
We found no evidence of statistically significant associ-
ations between SNPs in the TAS2R14 gene and colorectal
cancer risk.
We found that carriers of the G allele of the SNP
rs11610105 were more likely to be light smokers than
being heavy smokers. This finding was observed only in
the heterozygous individuals and only in controls, and
could thus be appealing because smoking habits and in
particular heavy smoking is a well known risk factor for
many cancer types. However, the finding was observed in
a population subgroup of a relatively small size (n = 167),
therefore this could be a chance finding and it has to be
taken with caution.
Conclusion
In conclusion we can confidently exclude a major role for
common polymorphisms of the TAS2R14 gene in col-
orectal cancer risk in this population, although in this
report we had insufficient statistical power to completely
exclude the possibility that rare variants of the TAS2R14
might be involved in colorectal cancer risk.
Table 2: Associations of TAS2R14 tagging polymorphisms with colorectal cancer risk
Position on 
Chromosome 12
Casesa Controlsa OR (95%)b P value P trend
rs3916060 10,984,340
T/T 603 537 1 1.00
T/C 52 50 0.93 (0.62-1.39) 0.71
C/C 2 0 N.A. N.A.
T/C+C/C 54 50 0.96 (0.64-1.44) 0.85
rs3741843 10,982,699
A/A 509 450 1 0.32
A/G 143 109 1.11 (0.43-2.82) 0.83
G/G 10 8 1.16 (0.88-1.53) 0.30
A/G+GG 153 117 1.16(0.88-1.52) 0.30
rs11610105 10,980,242
G/G 304 283 1 0.75
A/G 275 239 0.84(0.56-1.25) 0.39
A/A 55 61 1.07(0.84-1.36) 0.57
A/G+GG 330 300 1.02(0.82-1.28) 0.84
a Numbers may not add up to 100% of subjects due to genotyping failure. All samples that did not give a reliable result in the first round of 
genotyping were resubmitted to up to two additional rounds of genotyping. Data points that were still not filled after this procedure were 
left blank.
b OR: odds ratio; CI: confidence interval. Adjusted for age and gender.
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